ADM: Valuation Warnings
Morgan Stanley maintains cautious ADM view amid overvaluation and mixed analyst ratings
Anonymous
Key Points
1
Barclays raised ADM's target to $85 with an Equal Weight rating, UBS lifted to $95 and rated the stock Buy, Jefferies increased to $77 with a Hold rating, and Wall Street Zen upgraded ADM to Buy while Weiss Ratings maintained a Hold (c). This reflects a broad mix of opinions among peers despite Morgan Stanley's continued underweight stance.
2
ADM reported $0.71 per share for the latest quarter on revenue of about $20.49 billion, beating consensus on EPS but coming in below the expected revenue of about $21.35 billion.
3
GuruFocus assigns ADM a GF Score of 72/100 and a GF Value of $59.86, indicating the stock is roughly 43.5% overvalued at its current price of about $85.90.
4
ADM has an approximate market capitalization of $41.4 billion and operates as a major processor of oilseeds, corn, and wheat, with a nutrition business spanning both human and animal ingredients.
Morgan Stanley kept its Underweight rating on Archer Daniels Midland while nudging its price target up to $60 from $58, according to Benzinga. The move signals caution — ADM shares trade near $85.90, which is roughly 43% above where analysts think the stock should be.
The firm's analyst Vincent Andrews made the call despite ADM beating earnings estimates last quarter. The stock's price-to-earnings ratio sits at 38.52x — well above its 5-year median — raising questions about whether the current price is built on solid ground, according to GuruFocus.
Morgan Stanley Sees the Stock as Too Expensive
Morgan Stanley's Underweight rating is a signal to own less of the stock than the market average. The $60 target implies ADM shares would need to fall roughly 30% from their current price to reach fair value. That is a steep gap.
GuruFocus assigns ADM a GF Value of $59.86 — nearly identical to Morgan Stanley's target. The site's GF Score stands at 72 out of 100, which reflects average business quality. At $85.90 per share, GuruFocus flags the stock as about 43.5% overvalued and warns of elevated risk for new buyers.
ADM Beat Earnings but Missed on Revenue
ADM posted $0.71 per share in earnings for its latest quarter. That beat Wall Street's consensus estimate. Revenue came in at about $20.49 billion, which missed the expected $21.35 billion by roughly $860 million.
The earnings beat gives bulls something to point to. But the revenue miss matters for a commodity processor like ADM. The company handles oilseeds, corn, and wheat, and also runs a nutrition business for human and animal ingredients. Volume and top-line growth drive the story here — and that line fell short.
Other Analysts Are Divided on Where ADM Heads Next
Not everyone shares Morgan Stanley's cautious view. Barclays raised its target to $85 with an Equal Weight rating. UBS went further, lifting its target to $95 and rating the stock a Buy. Jefferies set a $77 target with a Hold rating. Wall Street Zen upgraded ADM to Buy.
The range of targets — from $60 to $95 — shows how divided the Street is on ADM right now. Morgan Stanley's $60 target sits at the low end. UBS's $95 sits at the high end. That $35 spread is unusually wide for a company with a $41.4 billion market cap, according to GuruFocus.
What the Valuation Gap Means for Investors
A P/E ratio of 38.52x means investors are paying $38.52 for every $1 of earnings ADM generates. That is high for an agricultural commodities company, which typically trades at lower multiples. ADM's own 5-year median P/E is well below where the stock trades today.
Morgan Stanley's raised target — even at $60 — does not mean the firm is turning bullish. It may simply reflect updated earnings models. The Underweight rating still stands, according to Benzinga. For investors already holding ADM, the mixed signals from peers offer little clear direction.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
11
Articles
7
Reach
18
A
AnonymousAuthor